Skip Navigation



Carcinogenesis Advance Access published online on March 31, 2009

Carcinogenesis, doi:10.1093/carcin/bgp072
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
30/6/927    most recent
bgp072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kim, A.
Right arrow Articles by Lim, J.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, A.
Right arrow Articles by Lim, J.-S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Suppression of NF-{kappa}B activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells

Aeyung Kima, Myung-Jin Kima, Young Yanga, Jae Wha Kimb, Young Il Yeomc and Jong-Seok Lima,*

a Department of Biological Science and the Research Center for Women's Diseases, Sookmyung Women's University, Seoul 140-742, Republic of Korea
b Stem Cell Center
c Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-333, Republic of Korea

* To whom correspondence should be addressed. Department of Biological Science and the Research Center for Women's Diseases, Sookmyung Women's University, Chungpa-Dong, Yongsan-Gu, Seoul, 140-742, Republic of Korea. Tel: +82-2-710-9560, Fax: +82-2-2077-7322, E-Mail: jslim{at}sookmyung.ac.kr

Down-regulation of the NDRG2 gene is involved in the progression of aggressive forms of cancer, along with the poor prognosis of cancer patients. In the current study, we examined the effect of NDRG2 expression on the metastatic potential of HT1080 human fibrosarcoma and B16F10 murine melanoma cells in both in vitro and in vivo systems. In gelatin zymography, NDRG2 expression remarkably suppressed the MMP-9 activity and slightly inhibited MMP-2 activity of both cell lines. Tumor migration and invasion in vitro was significantly reduced by NDRG2 expression, and NDRG2 inhibited tumor cell proliferation in an anchorage-independent semi-solid agar assay. Specifically, we found that NDRG2 affects invasion through suppression of NF-{kappa}B activity. In animal experiments, subcutaneously injected B16F10-NDRG2 cells showed delayed tumor growth compared to B16F10-mock cells. Furthermore, severe metastasis from primary tumor mass into the draining lymph nodes was observed after injection of B16F10-mock cells, but not with B16F10-NDRG2 cells. Pulmonary metastasis after intravenous injection of B16F10 cells was also reduced by NDRG2 expression. Intra- and peri-tumoral angiogenesis which is critical for the tumor growth and metastasis was clearly found in tumors after injection with B16F10-mock cells, while it was impaired in tumors after injection with B16F10-NDRG2 cells. Collectively, our data show that NDRG2 expression significantly suppresses tumor invasion by inhibiting MMP activities, which are regulated through the NF-{kappa}B signaling. Moreover, results from animal experiments provide evidence for the regulatory role of the NDRG2 gene in metastatic tumors.

Received November 22, 2008; revised February 28, 2009; accepted March 20, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.